Detection of patients with lung cancer out of a risk group by breath sample presentation to sniffer dogs

R. Ehmann, E. Boedeker, U. Friedrich, J. Sagert, T. Walles, G. Friedel (Stuttgart, Gerlingen, Löffingen, Germany)

Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Session: Biomarkers and other new methods for lung cancer
Session type: Thematic Poster Session
Number: 2787
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Ehmann, E. Boedeker, U. Friedrich, J. Sagert, T. Walles, G. Friedel (Stuttgart, Gerlingen, Löffingen, Germany). Detection of patients with lung cancer out of a risk group by breath sample presentation to sniffer dogs. Eur Respir J 2011; 38: Suppl. 55, 2787

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of breath sampling procedures in lung cancer patients
Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology
Year: 2008

What is real prevalence of COPD in patients with lung cancer?
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008


Incidence of lung cancer among COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 494s
Year: 2005

Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon
Source: Eur Respir J 2012; 39: 669-676
Year: 2012



Role of progestrin releasing peptide (ProGRP), a serum based biomarker in early diagnosis of SCLC in cohort of high-risk patient presenting with symptoms related to lung cancer
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012


The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005

Stage I lung cancer patients with or without symptoms – are the patients any different?
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020


Symptomatic pattern, alarm symptoms and diagnostic delay in a cohort of 1277 lung cancer patients
Source: Eur Respir J 2003; 22: Suppl. 45, 360s
Year: 2003

Characteristics of nonsmoker lung cancer patients
Source: Eur Respir J 2006; 28: Suppl. 50, 781s
Year: 2006

Prevalence of and risk factors for pulmonary complications after lung cancer surgery in elderly patients with preserved lung function
Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Year: 2018


Influence of the lung resection to sleep disorders in patients with lung cancer – pilot study on 10 patients
Source: Annual Congress 2008 - Risk assessment and treatment of complications in thoracic surgery patients
Year: 2008

An electronic nose in the discrimination of patients with lung cancer and controls
Source: Annual Congress 2012 - Early detection of lung cancer
Year: 2012


Significance of febrile episode in patients with lung cancer during therapy - comparison of NSCLC and SCLC patients
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002

Analysis of the clinical feature of 383 patients with lung cancer
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011

Prior lung disease and risk of lung cancer in women
Source: Eur Respir J 2005; 26: Suppl. 49, 598s
Year: 2005

Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009


Early detection of lung cancer in patients with COPD by eNose technology
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018




Features of an estimation of the functional condition of patients with complicated lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 11s
Year: 2004

Pulmonary function testing in patients with lung cancer
Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology
Year: 2012

Evaluation of cancer-associated thrombosis risk in patients with lung adenocarcinoma using the COMPASS-CAT risk assessment model
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021